Skip to main content
. Author manuscript; available in PMC: 2023 Mar 7.
Published in final edited form as: Mol Pharm. 2022 Feb 2;19(3):775–787. doi: 10.1021/acs.molpharmaceut.1c00373

Figure 6. Distributions of Fv isoelectric for approved antibody drugs and human antibodies in general.

Figure 6.

Distribution of Fv isoelectric points for (A) 79 approved antibodies (median pI of 8.14) and (B) 14037 human antibodies (median pI of 8.34).